FilingIndex
10-KThe Record

Acrivon Therapeutics, Inc. files 10-K

Filed Mar 28, 2024 · 2y ago · Accession 0000950170-24-037618

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
ACRV
CIK
1781174
Form type
10-K
Filing date
Mar 28, 2024
Report date
Dec 31, 2023
Document
acrv-20231231.htm
Size
90.1 MB